Cargando…

Hepatitis B Virus Reactivation under Treatment with Nilotinib

Hepatitis B virus (HBV) reactivation with imatinib, a tyrosine kinase inhibitor, has been reported in chronic myeloid leukemia. Nilotinib is a more potent second generation tyrosine kinase inhibitor and it inhibits the Src-family kinase LCK and hamper proliferation and function of CD8 (+) T lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Temel, Tuncer, Gunduz, Eren, Sadigova, Esmira, Uskudar Teke, Hava, Meric Ozgenel, Safak, Harmanci Ozakyol, Aysegul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578539/ https://www.ncbi.nlm.nih.gov/pubmed/29201705 http://dx.doi.org/10.5005/jp-journals-10018-1147

Ejemplares similares

A Case Report of Ulcerative Colitis Induced by Therapy of Colorectal Carcinoma
por: Temel, Tuncer, et al.
Publicado: (2015)

Complete Eradication of Bleeding Duodenal Varices with Endoscopic Polydocanol Sclerotherapy
por: Temel, Tuncer, et al.
Publicado: (2016)

Abdominal Inflammatory Myofibroblastic Tumor: A Rare Case
por: Tastekin, Fatih, et al.
Publicado: (2016)

Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report
por: Üsküdar Teke, Hava, et al.
Publicado: (2014)

Serum Thrombopoietin Levels and Its Relationship With Thrombocytopenia in Patients With Cirrhosis
por: Temel, Tuncer, et al.
Publicado: (2014)

Are the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients?
por: Üsküdar Teke, Hava, et al.
Publicado: (2015)

Management of Relapsed Hodgkin Lymphoma During the Second Trimester of Pregnancy: Case Report
por: Yaman, Fatih, et al.
Publicado: (2023)

Comparison of 64-Detector CT Colonography and Conventional Colonoscopy in the Detection of Colorectal Lesions
por: Devir, Cigdem, et al.
Publicado: (2016)

Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration
por: Goren Sahin, Deniz, et al.
Publicado: (2013)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Blue Lunula Related with Hydroxyurea
por: Üsküdar Teke, Hava, et al.
Publicado: (2013)

Menorrhagia due to uterine amyloidosis in familial Mediterranean fever: case-based review
por: Cansu, Döndü Üsküdar, et al.
Publicado: (2020)

Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report
por: Teke, Hava Üsküdar, et al.
Publicado: (2014)

Splenic Infarct in a Patient with Autoimmune Hemolytic Anemia
por: Üsküdar Teke, Hava, et al.
Publicado: (2012)

Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience
por: Üsküdar Cansu, Döndü, et al.
Publicado: (2021)

Pain Assessment in Hemodialysis Patients
por: Sadigova, Esmira, et al.
Publicado: (2020)

The Long-Term Outcomes for Patients with Budd-Chiari Syndrome Caused by Behcet’s Disease: A Case Series on the Results, from Cirrhosis to Death
por: Cansu, Dondu Uskudar, et al.
Publicado: (2016)

Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics
por: Suner, Aslı, et al.
Publicado: (2018)

Nilotinib-Associated Destructive Thyroiditis
por: Bakerywala, Suhalia, et al.
Publicado: (2015)

Nilotinib-Induced Keratosis Pilaris
por: Leong, Wai Mun Sean, et al.
Publicado: (2016)

Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
por: Na, Yoo Jin, et al.
Publicado: (2021)

First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia
por: Kim, Da Jung, et al.
Publicado: (2019)

Nilotinib based pharmacophore models for BCRABL
por: Sabitha, Kesavan
Publicado: (2012)

Nilotinib – Differentiating the Hope from the Hype
por: Wyse, Richard K., et al.
Publicado: (2016)

Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
por: Hochhaus, Andreas, et al.
Publicado: (2015)

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
por: Hochhaus, Andreas, et al.
Publicado: (2023)

The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)
por: Işık, Sevgi, et al.
Publicado: (2022)

Effects of nilotinib on regulatory T cells: the dose matters
por: Fei, Fei, et al.
Publicado: (2010)

Nilotinib-induced Perforating Folliculitis: Two Cases
por: Saraswat, Neerja, et al.
Publicado: (2018)

Nilotinib: QTc prolongation: 2 case reports
Publicado: (2021)

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib
por: Boons, Christel C. L. M., et al.
Publicado: (2020)

Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?
por: Harmancı, Özgür, et al.
Publicado: (2014)

Development and targeted use of nilotinib in chronic myeloid leukemia
por: Fava, Carmen, et al.
Publicado: (2009)

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
por: Pagan, Fernando, et al.
Publicado: (2016)

Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation
por: Contreras, Osvaldo, et al.
Publicado: (2018)

A Case of Severe, Nilotinib-Induced Liver Injury
por: Belopolsky, Yuliya, et al.
Publicado: (2019)

Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
por: Turner, Raymond S., et al.
Publicado: (2020)

Nilotinib-induced liver injury: A case report
por: Tan, Youwen, et al.
Publicado: (2020)

Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib
por: Cauchi, C., et al.
Publicado: (2011)

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ams3hm0bebr7muek77c17e1cdh